| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Department of Pharmacological and Physiological Science, St. Louis University School of Medicine (J.Y.), St. Louis, Missouri 63104; and the Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine (M.C.B.), Boston, Massachusetts 02111
Address all correspondence and requests for reprints to: Dr. Margery C. Beinfeld, Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine, 136 Harrison Avenue, Boston, Massachusetts 02111. E-mail: mbeinfel{at}opal.tufts.edu
Two endocrine tumor cell lines from pancreas (RIN5F) and intestine (STC-1) express cholecystokinin (CCK) messenger RNA and are able to posttranslationally process pro-CCK to CCK-22 and CCK-8 amide. Both of these forms are also secreted by these cells. Because they make and secrete forms of amidated CCK larger than CCK-8, they represent a model of pro-CCK processing in the gut and allow investigation of possible mechanisms for tissue differences in prohormone processing.
Both of these cells express two endoproteases convertase-1 (PC1) also known as PC3 and prohormone convertase-2 (PC2), which may be involved in pro-CCK processing. We have previously shown than inhibition of PC1 expression in these cells using stable expression of antisense messenger RNA caused a significant reduction in cellular content of amidated CCK and caused a selective depletion of CCK-8 with a comparative sparing of CCK-22. We demonstrate here that inhibition of PC2 expression in these cells also caused a large initial decrease in CCK content and produced a selective depletion of CCK-22 and a comparative sparing of CCK-8. These results support both a role for both PC1 and PC2 in pro-CCK processing in these cells and the hypothesis that tissue-specific processing of pro-CCK may be explained by differences in expression or activity of PC1 and PC2.
This article has been cited by other articles:
![]() |
M. C. Chen, S. V. Wu, J. R. Reeve Jr., and E. Rozengurt Bitter stimuli induce Ca2+ signaling and CCK release in enteroendocrine STC-1 cells: role of L-type voltage-sensitive Ca2+ channels Am J Physiol Cell Physiol, October 1, 2006; 291(4): C726 - C739. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-M. Khatib, G. Siegfried, M. Chretien, P. Metrakos, and N. G. Seidah Proprotein Convertases in Tumor Progression and Malignancy : Novel Targets in Cancer Therapy Am. J. Pathol., June 1, 2002; 160(6): 1921 - 1935. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-M. Lee, Q. He, E. W. Englander, and G. H. Greeley Jr. Endocrine Disruptive Effects of Polychlorinated Aromatic Hydrocarbons on Intestinal Cholecystokinin in Rats Endocrinology, August 1, 2000; 141(8): 2938 - 2944. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. V. Apletalina, L. Muller, and I. Lindberg Mutations in the Catalytic Domain of Prohormone Convertase 2 Result in Decreased Binding to 7B2 and Loss of Inhibition with 7B2 C-terminal Peptide J. Biol. Chem., May 5, 2000; 275(19): 14667 - 14677. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Viale, C. Ortola, G. Hervieu, M. Furuta, P. Barbero, D. F. Steiner, N. G. Seidah, and J.-L. Nahon Cellular Localization and Role of Prohormone Convertases in the Processing of Pro-melanin Concentrating Hormone in Mammals J. Biol. Chem., March 5, 1999; 274(10): 6536 - 6545. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |